Skip to main content
BMJ Open logoLink to BMJ Open
. 2019 May 16;9(5):e025417. doi: 10.1136/bmjopen-2018-025417

Vaginal herb use and Chlamydia trachomatis infection: cross-sectional study among women of various ethnic groups in Suriname

Jannie J Van der Helm 1, Maarten Franciscus Schim van der Loeff 1, Esther de Vries 1, Charlotte van der Veer 1, Antoon W Grünberg 2, Dennis Mans 3, Henry J C de Vries 1,4
PMCID: PMC6530446  PMID: 31101696

Abstract

Objective

Vaginal steam baths with herb leaves (herb use) is practised by some Surinamese women. We assessed herb use among women from the five most prevalent ethnic groups, and if herb use is associated with Chlamydia trachomatis infection.

Setting

Participants were recruited at a sexually transmitted infection (STI) clinic and a family planning clinic (FP) in Paramaribo, Suriname.

Participants

1040 women were included subsequently, comprising the following ethnic groups: Creole (26.7%), Hindustani (24.6%), Javanese (15.7%), Maroon (13.3%) and mixed descent (19.7%).

Methods

Nurses collected a questionnaire and vaginal swabs for nucleic acid amplification C. trachomatis testing.

Primary outcomes

Determinants of vaginal herb use and C. trachomatis infection via univariable and multivariable logistic regression.

Results

Herb use was most common among Maroon (68.8%) and Creole women (25.2%). In multivariable analysis including only Maroon and Creole women, determinants significantly associated with vaginal herb use were (OR; 95% CI): Maroon ethnic descent (5.33; 3.26 to 8.71 vs Creole), recruitment at the STI clinic (2.04; 1.24 to 3.36 vs FP), lower education levels (3.80; 1.68 to 8.57 lower vs higher, and 2.02; 0.90 to 4.51 middle vs higher). Lower age and recruitment at the STI clinic were associated with C. trachomatis infection, but not vaginal herb use.

Conclusion

In Suriname, vaginal herb use is common among Maroon and Creole women. Education, ethnic group and recruitment site were determinants for herb use. Vaginal herb use was not a determinant of C. trachomatis infection. Future research should focus on the effect of herb use on the vaginal microbiome and mucosal barrier.

Keywords: herb therapy, vaginal douching, vaginal, ethnicity, Suriname


Strengths and limitations of this study.

  • This is the first study into the relationship between vaginal herb use and a sexually transmitted infection (STI) in Suriname.

  • Moreover, determinants such as education and ethnic group are related to vaginal herb use.

  • Patients were recruited at two different settings, an STI outpatient clinic versus a family planning clinic, allowing a broader analysis of various populations.

  • We did not assess if vaginal herbs were used intravaginally and/or externally.

  • We did not study the effect of vaginal herb use on the vaginal microbiota.

Introduction

Depending on cultural habits, women worldwide engage in a variety of vaginal hygiene practices, such as the use of intravaginal douches, herbal vaginal steam baths or the direct insertion of herbs into the vagina.1–4 Studies in the USA showed that women who had less income, less education, were unmarried, lived in the southern States and were of African–American descent were more likely to engage in such practices when compared with white women.2

Vaginal practices are intended for feeling clean and fresh, getting rid of vaginal malodour, or removing residual menstrual blood,5 6 and for improving the appearance of the vagina and for enhancing sensation during intercourse, and securing the relationship with, and economic support by the male partner.2 However, these practices may increase the risk of acquiring infections, such as HIV,4 human papiloma virus,7 but also bacterial sexually transmitted infections (STI) and trichomoniasis.8 Particularly, intravaginal practices, such as use of water and soap, the insertion of a cloth or a piece of paper into the vagina, to dry and tighten the vagina was associated with acquiring HIV.4 An underlying mechanism for this may be that intravaginal practices deplete the relative amount of vaginal Lactobacillus sp. 4 9 Lactobacilli produce antimicrobials and acidify the vagina by lactic-acid production and are thus considered to be a hallmark for vaginal health; their depletion is known to mediate HIV and STI acquisition.4 10–13

Risk for STI may be further increased by a breakdown of the vaginal epithelial barrier and sometimes even the occurrence of lacerations.3 In addition, a lack of vaginal fluids increases the risk of condom rupture. Although several studies have reported an association between vaginal practices and STI,1 8 14 other studies did not.15 16 Unfortunately, earlier studies did not consider the type of vaginal practice nor the frequency of their use.

Suriname is located on the northeast coast of South America, bordering the Atlantic Ocean to the north and surrounded by French Guiana to the east, Brazil to the south and Guyana to the west. The population of approximately 570 000 is characterised by the ethnical and cultural diversity. The largest ethnic groups are the Creoles and Maroons (both originating from enslaved Africans imported in the 17th to 19th century), and the Hindustani and Javanese (descendants from indentured labourers from the former British Indies and Dutch Indies respectively, who arrived around the turn of the 20th century). There are, in addition, Indigenous Amerindians, people of mixed descent, and descendants from Chinese labourers, European colonists and immigrants from various Latin American and Caribbean countries such as Brazil, Guyana, French Guiana, Haiti and Cuba.17

Among these ethnic groups, Afro-Surinamese women (Creoles and Maroons) in particular engage in a variety of vaginal practices including vaginal steam baths containing certain herbs for drying and tightening the vagina, cleansing after menstruation or after birth to prevent puerperal fever, ‘placing the uterus back into position’, or preventing a flabby abdominal wall.3 Typically, for a herbal genital steam bath, a woman sits with spread legs on a bucket or bidet containing warm water with certain herbs to steam her inner genital parts. Depending on the herbs, the cooled down bath is used to wash the genital parts after steaming.18 For direct internal application, Dettol (the brand name of the antiseptic chloroxylenol), yoghurt, lemon juice, vinegar as well as commercial products such as effervescent tablets, gels or emulsions are used. Commercial products in the form of wipes, emulsions, crèmes and mousses can also be used externally.3 18

In this study, we examined the type and frequency of vaginal practices in women visiting an STI outpatient clinic and a family planning (FP) clinic; in particular, the use of herbs and the reasons for their use were identified. Moreover, we assessed factors associated with vaginal herb use, and examined whether vaginal herb use is a determinant of cervicovaginal Chlamydia trachomatis infection.

Methods

The data used for the current study were gathered in the course of a larger study concerning chlamydia, the Urogenital Chlamydia Rapid Test Evaluation in Paramaribo and Amsterdam (CUSTEPA) study.17 19 20

Study population

Recruitment took place in Suriname’s capital city Paramaribo in the period 2009–2010 at two locations: the Dermatological Service, an integrated outpatient STI clinic that offers free-of-charge examination and treatment of STIs and infectious skin diseases such as leprosy and leishmaniasis; and the Lobi Foundation, an FP clinic. The study was cross sectional, and each participant was given a unique code. Subsequently, a nurse interviewed the participant about demographic characteristics, including self-reported ethnic background, sexual behaviour, symptoms, STI history and vaginal hygiene. Criteria for exclusion were age below 18 years and previous participation within the CUSTEPA study.

Patient and public involvement

Representatives of the Maroon population were consulted on the outcome of the study.

Vaginal hygiene practices

Using a structured questionnaire, nurses asked women in detail about the use of products for vaginal practices such as douches, herbs or other home-made products, and if so, at which frequency. The questionnaires included several options such as the use of herbal genital steam baths, vinegar, water, yoghurt, and two often used commercial products: Lactacyd (Omega Pharma Nederland BV, Rotterdam, The Netherlands) that consists of lactic acid-containing wipes, crèmes, emulsion and mousses, and Dettol (Reckitt Benckiser Group, Slough, UK). Participants could specify the products they used. Precoded answer options for the frequency of vaginal practices were: daily, weekly, monthly or less than once a month. Women who used vaginal herbs were asked about their most recent application, and the reasons for use (hygiene, sexual pleasure, health or other). Items mentioned under reason ‘other’ that fitted one of the three former reasons were regrouped accordingly.

Specimen collection and testing procedures

Vaginal swabs were collected by trained nurses, stored and shipped to the Public Health Laboratory in Amsterdam, as described earlier.19 Here, the samples were tested for C. trachomatis rRNA (APTIMA CT, Hologic Gen-Probe, San Diego, USA) according to the manufacturer’s instructions. Test results were sent to the clinics in Suriname, and participants (and partners if indicated) were managed as described earlier.19

Statistical analysis

To examine whether epidemiological characteristics and behaviour, including the use and frequency of vaginal practices, differed between women from the five major ethnic groups, characteristics and behaviours of these groups were compared using the χ2 test; age was compared using the Kruskal-Wallis test. Univariable logistic regression analysis was used to assess determinants for the use of vaginal herbs. In univariable analysis, the following variables were assessed: age, education, ethnic group, ethnicity of sexual partner, recruitment site, condom use, number of sexual partners in the preceding 1 and 12 month(s), having had sex in exchange for money or goods, and vaginal symptoms. Variables with p<0.05 in univariable analysis were entered into multivariable logistic regression models; variables were removed stepwise until only significant variables were retained, but based on earlier studies age was forced into the model.1 2 A second logistic regression analysis was conducted to assess whether vaginal herb use was independently associated with C. trachomatis infection. Variables univariately associated with C. trachomatis infection were entered into a multivariable model, and stepwise removed until only significant variables were retained; vaginal herb use was forced into the model. P values <0.05 were considered statistically significant. SPSS statistics V.21 (IBM) was used for the analysis.

Results

Study population

We initially included 1093 women who self-identified with one of the following ethnic backgrounds: 17 (1.6%) Caucasian, 12 (1.1%) Chinese, 278 (25.4%) Creole, 256 (23.4%) Hindustani, 19 (1.7%) Indigenous, 163 (14.9%) Javanese, 138 (12.6%) Maroon, 205 (18.8%) mixed descent and 5 unknown (0.5%). Due to the small numbers, we excluded Caucasian, Chinese, Indigenous women and women with unknown background from further analysis. As a result, the study population included 1040 women of either Creole, Hindustani, Javanese, Maroon or mixed descent (table 1).

Table 1.

Epidemiological characteristics of Creole, Hindustani, Javanese, Maroon and mixed descent women (n=1040) recruited at the family planning clinic and sexually transmitted infections (STI) clinic, Paramaribo, Suriname, 2009–2010

Creole Hindustani Javanese Maroon Mixed descent P value
(n=278) (n=256) (n=163) (n=138) (n=205)
n (%) n (%) n (%) n (%) n (%)
Demographic characteristics
 Recruitment site <0.001
  Family planning clinic 199 (71.6) 226 (88.3) 146 (89.6) 85 (61.6) 138 (67.3)
  STI clinic 79 (28.4) 30 (11.7) 17 (10.4) 53 (38.4) 67 (32.7)
 Median age in years (IQR) 29 (24–35) 31 (26–39) 30 (25–36) 28 (23–34) 27 (23–33) <0.001
 Age in years
  <25 81 (29.1) 44 (17.2) 39 (23.9) 48 (34.8) 69 (33.7) 0.001
  25–29 64 (23.0) 63 (24.6) 41 (25.2) 29 (21.0) 53 (25.9)
  30–34 60 (21.6) 50 (19.5) 33 (20.2) 30 (21.7) 40 (19.5)
  ≥35 73 (26.3) 99 (38.7) 50 (30.7) 31 (22.5) 43 (21.0)
  Education <0.001
  Low 83 (29.9) 103 (40.2) 51 (31.3) 78 (56.5) 40 (19.5)
  Medium 147 (52.9) 130 (50.8) 89 (54.6) 41 (29.7) 109 (53.2)
  High 43 (15.5) 21 (8.2) 21 (12.9) 9 (6.5) 52 (25.4)
  Unknown 5 (1.8) 2 (0.8) 2 (1.2) 10 (7.2) 4 (2.0)
Symptoms
 Any symptoms 204 (73.4) 181 (70.7) 120 (73.6) 117 (84.8) 140 (68.3) 0.012
  Dysuria† 60 (21.8) 80 (31.2) 39 (23.9) 46 (33.6) 42 (20.6) 0.008
 Dyspareunia‡, § 66 (24.3) 73 (29.0) 41 (25.2) 41 (31.1) 51 (24.9) 0.506
  Change in fluor/vaginal discharge¶ 149 (54.0) 126 (49.2) 92 (56.4) 79 (57.7) 110 (53.7) 0.488
 Irregular menstruation** 81 (29.3) 71 (28.1) 32 (19.9) 51 (38.1) 52 (25.7) 0.012
  Abdominal pain†† 106 (39.8) 106 (41.9) 67 (42.1) 74 (54.4) 78 (38.6) 0.041
Vaginal hygiene
 Performs vaginal hygiene 109 (39.2) 51 (19.9) 29 (17.8) 112 (81.2) 78 (38.0) <0.001
 Vaginal products used‡‡
  Water 35 (12.6) 28 (10.9) 17 (10.4) 29 (21.0) 31 (15.1) 0.039
  Herbs 70 (25.2) 9 (3.5) 8 (4.9) 95 (68.8) 29 (14.1) <0.001
  Lactacyd 9 (3.2) 5 (2.0) 1 (0.6) 2 (1.4) 14 (6.8) 0.003
  Vinegar 9 (3.2) 2 (0.8) 4 (2.5) 2 (1.4) 9 (4.4) 0.118
  Dettol 4 (1.4) 4 (1.6) 0 (0.0) 0 (0.0) 0 (0.0) 0.105
  Other§§ 10 (3.6) 7 (2.7) 2 (1.2) 1 (0.7) 4 (2.0) 0.314
 Frequency of vaginal hygiene¶¶, *** 0.027
  Daily 36 (43.9) 11 (32.4) 7 (41.2) 53 (63.1) 25 (39.7)
  Once a week 18 (22.0) 12 (35.3) 3 (17.6) 19 (22.6) 11 (17.5)
  Once a month 19 (23.2) 7 (20.6) 5 (29.4) 7 (8.3) 20 (31.7)
  Less than once a month 9 (11.0) 4 (11.8) 2 (11.8) 5 (6.0) 7 (11.1)
 Reason for vaginal use of herbs‡‡,†††, ‡‡‡
  Hygiene 50 (71.4) 4 (44.4) 5 (62.5) 49 (51.6) 16 (55.2) 0.107
  Sexual 24 (34.3) 0 (0.0) 1 (12.5) 46 (48.4) 11 (37.9) 0.015, 0.485
  Health 11 (15.7) 0 (0.0) 1 (12.5) 16 (16.8) 2 (6.9) –*
  Other 3 (4.3) 0 (0.0) 0 (0.0) 6 (6.3) 0 (0.0)
 Last vaginal use of herbs§§§, ‡‡‡ –*
  Today 7 (12.7) 0 (0.0) 0 (0.0) 19 (26.4) 1 (5.9)
  Yesterday 5 (9.1) 0 (0.0) 0 (0.0) 23 (31.9) 1 (5.9)
  Last week 20 (36.4) 0 (0.0) 2 (33.3) 15 (20.8) 4 (23.5)
  More than a week ago 23 (41.8) 4 (100.0) 4 (66.7) 15 (20.8) 11 (64.7)
Sexual behaviour
 Number of partners in the preceding month¶¶¶ <0.001
  0 17 (6.2) 8 (3.1) 2 (1.2) 10 (7.5) 11 (5.7)
  1 237 (87.1) 236 (92.5) 148 (91.4) 117 (87.3) 158 (82.3)
  2 16 (5.9) 6 (2.4) 11 (6.8) 7 (5.2) 10 (5.2)
  >2 2 (0.7) 5 (2.0) 1 (0.6) 0 (0.0) 13 (6.8)
  Condom use during sex**** <0.001
  Always 49 (18.0) 17 (6.7) 10 (6.2) 23 (16.8) 37 (18.0)
  Never or inconsistent 223 (82.0) 236 (93.3) 152 (93.8) 114 (83.2) 168 (82.0)
 Number of partners in the preceding 12  months <0.001
  0 8 (2.9) 12 (4.7) 5 (3.1) 11 (8.0) 11 (5.4)
  1 208 (74.8) 209 (81.6) 123 (75.5) 82 (59.4) 127 (62.0)
  2 35 (12.6) 27 (10.5) 20 (12.3) 33 (23.9) 35 (17.1)
  >2 27 (9.7) 8 (3.1) 15 (9.2) 12 (8.7) 32 (15.6)
 Ethnic sexual mixing
  Reported≥1 sexual partner from another ethnic group 89 (32.0) 45 (17.6) 80 (49.1) 43 (31.2) 123 (60.0) <0.001
 Sex in exchange for money or goods§ 7 (2.6) 6 (2.4) 0 (0.0) 5 (3.7) 19 (9.4) <0.001
Chlamydia trachomatis infection†††† 37 (13.3) 16 (6.2) 25 (15.3) 15 (10.9) 29 (14.1) 0.022

*P values could not be obtained due to low numbers.

†Five missings.

‡Pain during sexual intercourse.

§Sixteen missings.

¶Three missings.

**Fourteen missings.

††Twenty-four missings.

‡‡Multiple options could be chosen.

§§Other vaginal practices are products like lactacyd but from other brands; soap, antifungal and eggs.

¶¶Ninety-nine missings.

***The denominator for the percentages is the group of women who indicated they performed vaginal hygiene.

†††Fifty-six missings, % of those who filled in the question,.

‡‡‡The denominator for the percentages is the group of women who indicated they performed vaginal hygiene.

§§§Fifty-seven missings.

¶¶¶Twenty-five missings.

****Eleven missings.

††††As diagnosed by nucleic acid amplification test.

The majority of participants were recruited at the FP clinic (between 61.6% and 89.6% per ethnic background). The median age ranged from 27 years (IQR, 23–33 years) for mixed descent women to 31 years (IQR, 26–39 years) for Hindustani women (p<0.001). Most women from Maroon descent (56.5%) had lower education whereas most of those from the other ethnic backgrounds had at least medium education (p<0.001).

Vaginal symptoms were reported frequently, ranging from 68.3% (mixed descent women) to 84.8% (Maroon women; p=0.01). In all ethnic groups, more than 80% of women reported one sexual partner during the preceding month, and more than 60% reported one sexual partner during the preceding 12 months. Discordant mixing (intercourse with a partner of a different ethnic group) was most frequently seen among mixed descent and Javanese women (60.0% and 49.1%, respectively), followed by Creole, Maroon and Hindustani women. The prevalence of C. trachomatis infections was highest in Javanese women (15.3%) followed by mixed descent women (14.1%) and Creole women (13.3%) (p=0.02).

Vaginal hygiene

Table 1 shows the ways in which vaginal hygiene was performed within the study population. Vaginal hygiene was most common in Maroon women (81.2%) followed by Creole (39.2%) and mixed descent women (38.0%). Between 10.4% and 21.0% of women used tap water for vaginal cleansing, with the largest proportion in Maroon (21.0%) and mixed descent women (15.1%). Lactacyd, vinegar and other substances such as Dettol were used less often.

In those women that performed vaginal hygiene, daily use was reported by Maroons (63.1%), Creoles (43.9%), Javanese (41.2%), mixed descent (39.7%) and Hindustani (32.4%).

Vaginal herb use

Vaginal herb use was reported most frequent by Maroon women (68.8%), followed by Creole women (25.2%), women of mixed descent (14.1%), Javanese (4.9%) and Hindustani (3.5%) (table 1). Hygiene was the most often mentioned reason for vaginal herb use (across all groups ranging from 68.1% to 100%), followed by sexual pleasure (ranging from 0% to 63.9%). Due to low numbers of women reporting vaginal herb use among women of Hindustani, Javanese and mixed descent, only Maroon and Creole women were included in the further analyses of vaginal herb use.

In univariable analysis, vaginal herb use was significantly associated with recruitment location, education, ethnic background, vaginal symptoms and abdominal pain (table 2). Although not significant, younger women reported vaginal herb use more often than women aged 35 years and above. In multivariable analysis, vaginal herb use was significantly associated with recruitment at the STI clinic (OR 2.04; 95% CI 1.24 to 3.36 vs the FP clinic), lower education levels (OR 3.80; 95% CI 1.68 to 8.57 lower vs higher education; and OR 2.02; 95% CI 0.90 to 4.51 medium vs higher education) and Maroon ethnicity (OR, 5.33; 95% CI 3.26 to 8.71 vs Creole). Although not significant in multivariable analysis, younger age was associated with vaginal herb use.

Table 2.

Univariable and multivariable logistic regression analyses of determinants associated with vaginal herb use among Creole and Maroon women, Paramaribo, Suriname, 2009–2010

Use of vaginal herbs Univariable OR (95% CI) P value Multivariable-adjusted OR (95% CI)* P value
n/N (%)
Demographic characteristics
 Ethnic groups
  Creole 70/278 (25.2) 1 <0.001 1 <0.001
  Maroon 95/138 (68.8) 6.57 (4.18 to 10.30) 5.33 (3.26 to 8.71)
 Recruitment site
  Family planning clinic 96/284 (33.8) 1 <0.001 1 0.005
  STI clinic 69/132 (52.3) 2.15 (1.41 to 3.27) 2.04 (1.24 to 3.36)
 Age in years 0.068 0.067
  <25 59/129 (45.7) 1.99 (1.15 to 3.42) 2.23 (1.17 to 4.27)
  25–29 35/93 (37.6) 1.42 (0.79 to 2.57) 1.78 (0.88 to 3.57)
  30–34 40/90 (44.4) 1.88 (1.04 to 3.40) 2.23 (1.13 to 4.42)
  ≥35 31/104 (29.8) 1 1
 Education† <0.001 0.002
  Low 88/161 (54.7) 5.06 (2.38 to 10.79) 3.80 (1.68 to 8.57)
  Medium 59/188 (31.4) 1.92 (0.90 to 4.09) 2.02 (0.90 to 4.51)
  High 10/52 (19.2) 1 1
Sexual behaviour
 Number partners preceding month‡ 0.106
  0 10/27 (37.0) 1
  1 135/354 (38.1) 1.05 (0.47 to 2.36)
  ≥2 15/25 (60.0) 2.55 (0.83 to 7.80)
 Number partners preceding 12 months 0.216
  0 9/19 (47.4) 1
  1 107/290 (36.9) 0.65 (0.26 to 1.65)
  ≥2 49/107 (45.8) 0.94 (0.35 to 2.50)
 Ethnic sexual mixing
  No 115/284 (40.5) 1 0.612
  Yes 50/132 (37.9) 0.90 (0.59 to 1.37)
 Sex in exchange for money or goods§
  No 155/396 (39.1) 1 0.191
  Yes 7/12 (58.3) 2.17 (0.68 to 6.98)
Symptoms
 Any symptoms
  No 24/95 (25.3) 1 0.001
  Yes 141/321 (43.9) 2.32 (1.39 to 3.87)
 Dysuria¶
  No 114/306 (37.3) 1 0.104
  Yes 49/106 (46.2) 1.45 (0.93 to 2.26)
 Dyspareunia (pain during sexual intercourse)**
  No 113/297 (38.0) 1 0.287
  Yes 47/107 (43.9) 1.28 (0.82 to 2.00)
 Change in fluor/vaginal discharge††
  No 71/185 (38.4) 1 0.619
  Yes 93/228 (40.8) 1.11 (0.74 to 1.65)
  Irregular menstruation‡‡
  No 102/278 (36.7) 1 0.122
  Yes 59/132 (44.7) 1.40 (0.92 to 2.13)
 Abdominal pain§§
  No 78/222 (35.1) 1 0.026
  Yes 83/180 (46.1) 1.58 (1.06 to 2.36)

*ORs in the multivariable model are adjusted for all factors for which adjusted ORs are shown. In the final model, 401 participants were included.

†Fifteen missings.

‡Ten missings.

§Eight missings.

¶Four missings.

**Twelve missings.

††Three missings.

‡‡Six missings.

§§Fourteen missings.

STI, sexually transmitted infections.

As described in table 3, a wide variety of herbs were used. Maroon women predominantly used ‘kill somebody’ or ‘kill your darling Dimorphandra conjugata (Splitg.) Sandw. (Fabaceae)’,13 the ‘jambolan or dyamu Syzygium cumini (L.) Skeels (Myrtaceae)’,9 the ‘towel or wasduku Clidemia capitellata (Bonpl.) D. Don (Melastomataceae)’,9 the ‘guavaberry or andoya Campomanesia aromatica (Aubl.) Griseb. (Myrtaceae)’,6 and ‘pikin bë/witi baka píyjá páu (small red/white backed pineapple) Vismia Vand. sp. (Hypericaceae)’.7 Creole women mostly mentioned ‘sea island cotton or redikatun Gossypium barbadense L. (Malvaceae)’16 in addition to the leaves of the ‘tropical-almond or amandra Terminalia catappa L. (Combretaceae)’, the ‘mess apple or broko pi (‘broken penis’) Bellucia grossularioides (L.) Triana (Melastomataceae)’, the ‘guava or guyaba Psidium guajava L. (Myrtaceae)’, the ‘jungle geranium or faya lobi (‘fiery love’) Ixora coccinea L. (Rubiaceae)’, and the ‘ant bush or kapasiwiwiri (‘herb of the nine-banded armadillo’) Siparuna guianensis Aubl. (Monimiaceae)’.

Table 3.

Vaginal products mentioned among female participants performing vaginal hygiene, Paramaribo, Suriname, 2009–2010

Vaginal product (scientific names if applicable) Maroon ethnicity (n=112) Creole ethnicity (n=109) Other ethnicities* (n=158)
Almond leaves (Terminalia catappa) 1 3 1
Andoya (Campomanesia aromatica) 6 1 1
Blaka masusa 0 1 0
Blaka uma 0 5 2
Broko pie (Bellucia grossularioides) 1 1 0
Dettol 0 4 4
Djamu (Syzygium cumini) 9 4 0
Douche gel 0 0 1
Dram (alcohol) 0 1 0
Eggs 0 1 0
Eva products 0 1 0
Faya lobi (Ixora coccinea) 2 0 0
Feififinga wiwiri 1 1 0
Guave (Psidium guajava) 3 2 0
Intimate wash products 0 3 5
Kill somebody (Dimorphandra conjugata) 13 4 1
Lactacyd 2 9 20
Manjablad (Mango leaves) 4 9 3
Odany jewa 0 0 3
Paraklem 4 1 0
Pedreku 1 1 2
Pikin bë (Vismia Vand. sp) 7 5 14
Redikatun (Gossypium barbadense) 4 16 6
Suku trobi 7 3 0
Twigs 0 0 1
Uma anesi 4 1 2
Unknown leaves 13 6 6
Vagisil 0 1 0
Vinegar 2 9 15
Wasduku (Clidemia capitellata) 9 1 3
Water 29 35 76
Yarakopie 2 3 1
Yoghurt 0 0 1

*Hindustani, Javanese and mixed race ethnicity.

Vaginal herb use and C. trachomatis infection

Vaginal herb use was not associated with C. trachomatis infection, neither in univariable nor in multivariable analysis (adjusted OR [aOR], 1.20; 95% CI 0.65 to 2.22, p=0.564; table 4). In contrast, recruitment location, age and reporting sex in exchange for money or goods were associated with C. trachomatis infection in univariable analysis. In multivariable analysis, chlamydia infection was associated with recruitment at the STI clinic versus FP clinic (OR, 2.59; 95% CI 1.39 to 4.83; p=0.003) and also with younger age, both for <25 years, and 25–29 years versus ≥35 years (resp aOR, 4.37; 95% CI 1.59 to 12.00, aOR 4.96; 95% CI 1.72 to 14.26 and aOR 1.20; 95% CI 0.33 to 4.35; p=0.002).

Table 4.

Univariable and multivariable logistic regression analyses of variables associated with cervicovaginal Chlamydia trachomatis infection among Creole and Maroon women, Paramaribo, Suriname, 2009–2010

NAAT positive Univariable OR (95% CI) P value Multivariable-adjusted OR (95% CI)* P value
n/N (%)
Demographic characteristics
 Ethnic group
  Creole 37/278 (13.3) 1 0.479
  Maroon 15/138 (10.9) 0.79 (0.42 to 1.50)
 Recruitment site
  Family planning clinic 25/284 (8.8) 1 0.001 1 0.003
  STI clinic 27/132 (20.5) 2.66 (1.48 to 4.80) 2.59 (1.39 to 4.83)
 Age in years 0.001 0.002
  <25 25/129 (19.4) 4.76 (1.75 to 12.92) 4.37 (1.59 to 12.00)
  25–29 17/93 (18.3) 4.43 (1.56 to 12.54) 4.96 (1.72 to 14.26)
  30–34 5/90 (5.6) 1.17 (0.33 to 4.16) 1.20 (0.33 to 4.35)
  ≥35 5/104 (4.8) 1 1
 Education 0.444
  Low 19/161 (11.8) 1.03 (0.39 to 2.73)
  Medium 23/188 (12.2) 1.07 (0.41 to 2.78)
  High 6/52 (11.5) 1
  Unknown 4/15 (26.7) 2.79 (0.67 to 11.60)
Vaginal hygiene
 Performed vaginal hygiene
  No 21/195 (10.8) 1 0.317
  Yes 31/221 (14.0) 1.35 (0.75 to 2.44)
 Herb use
  No 27/251 (10.8) 1 0.187 1 0.564
  Yes 25/165 (15.2) 1.48 (0.83 to 2.66) 1.20 (0.65 to 2.22)
 Frequency of performing vaginal hygiene†
  Daily 16/89 (18.0) 1.82 (0.90 to 3.68) 0.282
  At least once a week 7/36 (19.4) 2.00 (0.78 to 513)
  At least once a month 2/25 (8.0) 0.72 (0.16 to 3.28)
  Less then once a month 3/14 (21.4) 2.26 (0.58 to 8.76)
  Never 21/195 (10.8) 1
Sexual behaviour
 Number of partners preceding month‡
  0–1 43/381 (11.3) 1 0.018
  ≥2 7/25 (28.0) 3.06 (1.21 to 7.74)
 Condom use§
  Always 11/72 (15.3) 1.30 (0.63 to 2.68) 0.473
  Never or inconsistent 41/337 (12.2) 1
 Number of partners in the preceding 12 months
  0–1 37/309 12.0) 1 0.582
  ≥2 15/107 (14.0) 1.20 (0.63 to 2.28)
 Ethnic sexual mixing
  Reported only sexual partners from own ethnic group 32/284 (11.3) 1 0.267
  Reported at least one sexual partner from another ethnic group 20/132 (15.2) 1.41 (0.77 to 2.57)
 Sex in exchange for money or goods¶
  No 47/396 (11.9) 1 0.038
  Yes 4/12 (33.3) 3.71 (1.08 to 12.81)

*ORs in the multivariable model are adjusted for all factors for which adjusted ORs are shown. In the final model, 416 participants were included.

†Fifty-seven missings.

‡Ten missings.

§Seven missings.

¶Eight missings.

NAAT, nucleic acid amplification test; STI, sexually transmitted infection.

Discussion

We assessed the use and frequency of various vaginal practices among female STI clinic and FP clinic visitors in Suriname, and found that: (1) vaginal practices are commonly used, and most frequently by Maroon, Creole and mixed decent women; (2) vaginal herb use is more common among women with lower education; (3) vaginal herb use is most frequently practised for hygienic reasons and (4) vaginal herb use is not associated with C. trachomatis infection.

Ethnic background was the most important determinant for vaginal herb use. The extensive vaginal use of herbs among Maroon women has previously been described in French Guiana, where a prevalence of 96.1% was found.21

Women who experienced vaginal symptoms were more likely to engage in vaginal herb use. Since this is a cross-sectional study, it is not clear if vaginal symptoms are a cause, or an effect of vaginal practices. A Cambodian study also found an association between vaginal douching and vaginal symptoms.22 Similarly, female sex workers in China were more likely to engage in vaginal practices when having STI-related symptoms, and reportedly engaged more in vaginal douching when experiencing vaginal symptoms.23 In contrast, a study with Jamaican women who attended a public STI clinic found that vaginal itching led to a lower frequency of vaginal douching.24 Prospective (intervention) studies could shed light on any casual links between vaginal practices and vaginal symptoms. The high prevalence of vaginal herb use among Maroon women has been previously reported, and it is conceivable that Maroon women do not engage in vaginal herb use as consequence of vaginal symptoms but rather out of (cultural) habit.21

As previously described, hygiene was the most important reason for vaginal herb use, followed by sexual reasons.3 Moreover, Maroon women mentioned as a reason to make oneself more attractive for one’s partner.

We found no association between vaginal herb use and infection with C. trachomatis. This confirms earlier findings of the above-mentioned Chinese study where no association was found among sex workers between vaginal practices (mostly disinfectants after sex with clients) and STI (syphilis, Neisseria gonorrhoea and C. trachomatis combined).23

This study has some limitations. This study did not assess the mode of vaginal practices, for example, whether the products were applied intravaginally and/or externally. Previous studies have found associations between the internal use of vaginal practices and HIV.4 Therefore, we cannot exclude that the lack of association between vaginal herb use and C. trachomatis infection may be explained by predominantly external use of herbs. Moreover, we did not study the effect of vaginal herb use on the vaginal microbiota. Lactobacilli generally constitute a healthy vaginal microbiota as they generate an acidic environment (pH 4.0–4.5) and produce antimicrobials, that restrict the growth of most pathogens.25 A non-lactobacillus-dominated vaginal microbiota is thus considered dysbiotic. Intravaginal practices have been linked to developing vaginal dysbiosis,4 9 26 27 but these studies studied douching behaviour in general and did not differentiate between different types of intravaginal products. The use of an over-the-counter lactic acid containing douche was recently studied prospectively among healthy Dutch women and this was not found to significantly impact the vaginal microbiota composition, although an increased odds for having non-lactobacillus-dominated vaginal microbiota among users was observed.28 Additionally, douching significantly increased the odds for testing positive for Candida albicans. Three douching intervention studies failed to show a significant effect of douching cessation on the vaginal microbiota,9 29 although one study did observe significantly reduced candidiasis prevalence.30 The specific effect of herb use on the vaginal microbiota is currently unknown and may differ by study population and by specific herb used. Compared with Caucasian women, women of African descent are more likely to have vaginal microbiota not dominated by Lactobacillus sp. 11 31 32 More research is needed to evaluate the impact of vaginal herb use on the vaginal microbiome and its potential to cause dysbiosis. Since vaginal herb use involves female hygiene, sexuality and cultural identity, it is considered a sensitive subject in Surinamese society.33 Therefore, the anthropological and psychological aspects of vaginal herb use should be studied in detail to shed more light on this widely used phenomenon.

In conclusion, in the multiethnic society of Suriname, many Maroon and Creole women use vaginal herbs. Apart from ethnic group, education and being recruited at an STI clinic (as opposed to an FP clinic) were the main determinants for vaginal herb use. Vaginal herb use was not associated with C. trachomatis infection. Whether vaginal herb use has beneficial or possible negative effects on female health needs to be assessed in future studies.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

The author would like to thank Leslie O A Sabajo, all nurses and laboratory technicians of the Dermatological Service and the Lobi Foundation for data collection, and Titia Heijman for helpful suggestions.

Footnotes

Contributors: JJVdH collected the data, analysed the data and wrote the manuscript; MFSvdL supervised the analysis and wrote the manuscript; EdV analysed the data and wrote the first manuscript draft; CvdV wrote the manuscript; AWG designed the study, collected data and wrote the manuscript; DM collected the data and wrote the manuscript; and HJCdV designed the study, and wrote the manuscript.

Funding: This work was supported by the Research and Development fund of the Public Health Service of Amsterdam [project nos 2369 and 2371] and AGIS healthcare insurance [RVVZ no 1417000].

Competing interests: None declared.

Ethics approval: The study was approved by the Ethics Committees of the Ministry of Health of the Republic of Suriname (VG010-2007) and the Academic Medical Center, University of Amsterdam, The Netherlands (MEC07/127).

Provenance and peer review: Not commissioned; externally peer reviewed.

Data sharing statement: Deidentified participant data are available upon request through the corresponding author HJCdV. ORCID identifier 0000-0001-9784-547X.

Correction notice: This article has been corrected since it first published online. The open access licence type has been amended.

Patient consent for publication: Not required.

References

  • 1. Blythe MJ, Fortenberry JD, Orr DP. Douching behaviors reported by adolescent and young adult women at high risk for sexually transmitted infections. J Pediatr Adolesc Gynecol 2003;16:95–100. 10.1016/S1083-3188(03)00027-5 [DOI] [PubMed] [Google Scholar]
  • 2. Misra DP, Trabert B, Atherly-Trim S. Variation and predictors of vaginal douching behavior. Womens Health Issues 2006;16:275–82. 10.1016/j.whi.2006.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. van Andel T, de Korte S, Koopmans D, et al. Dry sex in Suriname. J Ethnopharmacol 2008;116:84–8. 10.1016/j.jep.2007.11.003 [DOI] [PubMed] [Google Scholar]
  • 4. Low N, Chersich MF, Schmidlin K, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med 2011;8:e1000416 10.1371/journal.pmed.1000416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Oh MK, Merchant JS, Brown P. Douching behavior in high-risk adolescents. What do they use, when and why do they douche? J Pediatr Adolesc Gynecol 2002;15:83–8. [DOI] [PubMed] [Google Scholar]
  • 6. Markham CM, Tortolero SR, Addy RC, et al. Factors associated with frequent vaginal douching among alternative school youth. J Adolesc Health 2007;41:509–12. 10.1016/j.jadohealth.2007.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Bui TC, Thai TN, Tran LT, et al. Association between vaginal douching and genital human papillomavirus infection among women in the United States. J Infect Dis 2016;214:1370–5. 10.1093/infdis/jiw388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Tsai CS, Shepherd BE, Vermund SH. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol 2009;200:38.e1–38.e8. 10.1016/j.ajog.2008.06.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Brotman RM, Klebanoff MA, Nansel TR, et al. A longitudinal study of vaginal douching and bacterial vaginosis–a marginal structural modeling analysis. Am J Epidemiol 2008;168:188–96. 10.1093/aje/kwn103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Borgdorff H, Tsivtsivadze E, Verhelst R, et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J 2014;8:1781–93. 10.1038/ismej.2014.26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Borgdorff H, van der Veer C, van Houdt R, et al. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS One 2017;12:e0181135 10.1371/journal.pone.0181135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Gosmann C, Anahtar MN, Handley SA, et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity 2017;46:29–37. 10.1016/j.immuni.2016.12.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. van der Veer C, Bruisten SM, van der Helm JJ, et al. The cervicovaginal microbiota in women notified for chlamydia trachomatis infection: a case-control study at the sexually transmitted infection outpatient clinic in Amsterdam, The Netherlands. Clin Infect Dis 2017;64:24–31. 10.1093/cid/ciw586 [DOI] [PubMed] [Google Scholar]
  • 14. Turner AN, Morrison CS, Munjoma MW, et al. Vaginal practices of HIV-negative Zimbabwean women. Infect Dis Obstet Gynecol 2010;2010:1–7. 10.1155/2010/387671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ness RB, Hillier SL, Kip KE, et al. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol 2005;161:186–95. 10.1093/aje/kwi025 [DOI] [PubMed] [Google Scholar]
  • 16. Ott MA, Ofner S, Fortenberry JD. Beyond douching: use of feminine hygiene products and STI risk among young women. J Sex Med 2009;6:1335–40. 10.1111/j.1743-6109.2008.01152.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. van der Helm JJ, Bom RJ, Grünberg AW, et al. Urogenital Chlamydia trachomatis infections among ethnic groups in Paramaribo, Suriname; determinants and ethnic sexual mixing patterns. PLoS One 2013;8:e68698 10.1371/journal.pone.0068698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. van ’t Klooster C, Haabo V, Ruysschaert S, et al. Herbal bathing: an analysis of variation in plant use among Saramaccan and Aucan Maroons in Suriname. J Ethnobiol Ethnomed 2018;14:20 10.1186/s13002-018-0216-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. van der Helm JJ, Sabajo LO, Grunberg AW, et al. Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname. PLoS One 2012;7:e32122 10.1371/journal.pone.0032122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Bom RJ, van der Helm JJ, Bruisten SM, et al. The role of Surinamese migrants in the transmission of Chlamydia trachomatis between Paramaribo, Suriname and Amsterdam, The Netherlands. PLoS One 2013;8:e77977 10.1371/journal.pone.0077977 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. van Melle A, Parriault MC, Basurko C, et al. Knowledge, attitudes, behaviors, and practices differences regarding HIV in populations living along the Maroni river: particularities of operational interest for Amerindian and Maroon populations. AIDS Care 2015;27:1112–7. 10.1080/09540121.2015.1032203 [DOI] [PubMed] [Google Scholar]
  • 22. Heng LS, Yatsuya H, Morita S, et al. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis. J Epidemiol 2010;20:70–6. 10.2188/jea.JE20081046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Li J, Jiang N, Yue X, et al. Vaginal douching and sexually transmitted infections among female sex workers: a cross-sectional study in three provinces in China. Int J STD AIDS 2015;26:420–7. 10.1177/0956462414543937 [DOI] [PubMed] [Google Scholar]
  • 24. Carter M, Gallo M, Anderson C, et al. Intravaginal cleansing among women attending a sexually transmitted infection clinic in Kingston, Jamaica. West Indian Med J 2013;62:56–61. [PMC free article] [PubMed] [Google Scholar]
  • 25. Hickey RJ, Zhou X, Pierson JD, et al. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res 2012;160:267–82. 10.1016/j.trsl.2012.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Hutchinson KB, Kip KE, Ness RB. Gynecologic Infection Follow-Through I. Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Sex Transm Dis 2007;34:671–5. [DOI] [PubMed] [Google Scholar]
  • 27. McClelland RS, Richardson BA, Graham SM, et al. A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex Transm Dis 2008;35:617–23. 10.1097/OLQ.0b013e31816907fa [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Veer CV, Bruisten S, Houdt RV. editors. O04.2 Effects of over-the-counter lactic acid-containing vaginal douching products on the vaginal microbiota. Sex Transm Infect 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Klebanoff MA, Andrews WW, Yu KF, et al. A pilot study of vaginal flora changes with randomization to cessation of douching. Sex Transm Dis 2006;33:610–3. 10.1097/01.olq.0000216050.41305.c1 [DOI] [PubMed] [Google Scholar]
  • 30. Sivapalasingam S, McClelland RS, Ravel J, et al. An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women. AIDS Res Hum Retroviruses 2014;30:1046–57. 10.1089/aid.2013.0251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 2011;108(Suppl 1):4680–7. 10.1073/pnas.1002611107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Fettweis JM, Brooks JP, Serrano MG, et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology 2014;160(Pt 10):2272–82. 10.1099/mic.0.081034-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Terborg JRH. Sexual behaviour and sexually transmitted diseases among Saramaka and Ndjuka Maroons in the hinterland of Suriname. Paramaribo: MZ Primary Health Care Suriname: ProHealth, 2001;83. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reviewer comments
Author's manuscript

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES